1
The primary end point was angiographic or clinical restenosis.
2
This is probably related to higher clinical restenosis rates.
3
This may explain that the increased clinical restenosis after positive remodeling lesions is treated with non-stent interventions.
4
A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI.
5
The incidence of a third clinical restenosis remains high, however, and is correlated with the interval between the previous angioplasty procedures.
6
A third clinical restenosis occurred in 22 (39%) of the 56 patients who had initially successful procedures.
7
Clinical restenosis was defined as the occurrence of a major adverse coronary events (MACE), within the follow-up period.
8
Clinical restenosis was treated by repeat percutaneous intervention in 11 patients, while 28 patients remained asymptomatic.